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Antioxidant effect of buspirone in epilepsy – Is the case closed?
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I read with interest a very comprehensive article titled “Antioxidant 
effect of buspirone in epilepsy model induced by pilocarpine” by Fer-
reira et al.1 published in the December issue of Revista de Psiquiatria 
Clínica. In brief, the authors demonstrated that the pretreatment with 
buspirone has an anticonvulsant and antioxidant effect during the 
acute period of pilocarpine model of temporal lobe epilepsy. Given 
the dearth of published data about the relation of buspirone and epi-
lepsy, we applaud Dr. Ferreira et al. for pursuing this topic, but I also 
find it necessary to address some purposes regarding their comments. 
Initially developed for use in the treatment of generalised anxiety 
disorder, it appears that buspirone may be useful in various other 
psychiatric and neurological disorders, such as attenuating side effects 
of Parkinson’s disease therapy, ataxia, depression, social phobia, and 
behaviour disturbances following brain injury, and those accompanying 
Alzheimer’s disease, dementia and attention deficit disorder2. Con-
cerning epilepsy, few studies have accurately assessed the relationship 
between buspirone, seizures, and chronic epilepsy. Following a chro-
nological sequence, Pranzatelli et al. showed in 1993 some inspiring 
proposals after evaluating the effects of buspirone administration in 
four individuals with progressive myoclonus epilepsy3. From experi-
mental point of view, it was shown two years later that buspirone, using 
the low Mg2+ induced model epilepsy, was effective in reducing the 
frequency of occurrence of low magnesium induced field potentials 
in CA1 and CA3 areas of the hippocampus slice preparation (guinea 
pigs) in a dose dependent manner4. In 2004, Macêdo et al. demonstra-
ted that small doses of buspirone protected against cocaine-induced 
seizures and/or mortality5. Recently, the research group led by De 
Freitas showed that buspirone exerted anticonvulsant effects associated 
with the inhibition of the development of oxidative stress caused by 
pilocarpine-induced seizures, suggesting a therapeutic use potential 
of buspirone in epilepsy treatment6.
In sum, the data presented by Ferreira et al.1 open up new 
avenues of research in epilepsy field. Obviously, many question still 
to be answered, such as: What are the effects of buspirone during 
epileptogenesis process in the pilocarpine model? Buspirone exerts 
antioxidant action in other brain structures, beyond the hippocampal 
formation? What is the effect of buspirone in animals with refractory 
epilepsy?
Finally, while these and other questions have not been answered, 
I express my congratulations to Ferreira et al. for the stimulating 
article and I am sure that the integration of the advancements in 
basic science with clinical trials allows us to create highly effective 
pharmacological strategies against uncontrolled epilepsy.
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